Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 32 million people in the US suffering with food allergies.

We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.

Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.

Please see our Terms of Service and Privacy Policy.

Emerging Therapy

Faster than Your Auto-Injector: Aquestive’s Sublingual Epinephrine Film Aces New Clinical Trials

Fecal Transplants Reveal a New Path Toward Peanut Allergy Treatment

Breakthroughs on the Horizon: FAF Funds Five New Studies Targeting Food Allergies

Next-Generation Peanut Allergy Therapy Earns FDA Fast Track Designation

As Food Allergy Treatments Become Big Business, Pharma Bets on VT-7208

Therapy Helps Children with Food Allergies Manage Severe Anxiety

Results of Aimmune’s Pivotal Phase 3 European Trial of PALFORZIA® Published...

Wheat OIT Shows Potential for Children in Small Study

Will the Viaskin “Patch” Therapy for Peanut Allergy be Approved Soon?...

Aquestive Files IND to Begin Clinical Trials of Sublingual Epinephrine

Intra-Nasal Epinephrine Takes Step Forward After Three Positive Pre-Clinical Studies

FDA Approves Dupixent® as First Biologic for Treatment of Children Aged...

Allerdent Enables Patients to Maintain Seasonal Allergy Immunotherapy During COVID-19 Pandemic

Oral Immunotherapy: What You Should Know, and What’s New (Webinar)

Pending Litigation Shows Food Allergy Treatments in Development are Sometimes Overhyped

Follow Us

Your School On Our Map

Put Your School on the Map